Mechanisms at the root of flavonoid action in cancer: A step toward solving the rubik's cube

Flavonoids: Biosynthesis, Biological Effects and Dietary Sources

Volumn , Issue , 2009, Pages 231-248

  Marino, Maria ^a   Bulzomi, Pamela ^a  

^a ROMA TRE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77951107225     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (104)

1. Acconcia, F., Ascenzi, P., Bocedi, A., Spisni, E., Tomasi, V., Trentalance, A., Visca, P., and Marino, M. (2005a). Palmitoylation-dependent estrogen receptor a membrane localization: regulation by 17ß-estradiol. Mol. Biol. Cell, 16, 231-238.
2. Acconcia, F., Totta, P., Ogawa, S., Cardillo, I., Inoue, S., Leone, S., Trentalance, A., Muramatsu, M., and Marino, M. (2005b). Survival versus apoptotic 17ß-estradiol effect: role of ERa and ERß activated non-genomic signaling. J. Cell. Physiol., 203, 193-201.
3. Adachi, T., Okuno, Y., Takenaka, S., Matsuda, K., Ohta, N., Takashima, K., Yamazaki, K., Nishimura, D., Miyatake, K., Mori, C., and Tsujimoto, G. (2005). Comprehensive analysis of the effect of phytoestrogen, daidzein, on a testicular cell line, using 1210 mRNA and protein expression profile. Food Chem. Toxicol., 43, 529-535.
4. Adlercreutz, H., Heinonen, S.M., and Penalvo-Garcia, J. (2004). Phytoestrogens, cancer and coronary heart disease. Biofactors, 22, 229-236.
5. Albini, A., Tosetti, F., Benelli, R., and Noonan, D.M. (2005). Tumor inflammatory angiogenesis and its chemoprevention. Cancer Res., 65, 10637-10641.
6. Andreadi, C. K., Howells, L.M., Atherfold, P.A., and Manson, M.M. (2006). Involvement of Nrf2, p38, B-Raf, and nuclear factor-κB, but not phosphatidylinositol 3-kinase, in induction of hemeoxygenase-1 by dietary polyphenols. Mol. Pharmacol., 69, 1033-1040.
7. Ascenzi, P., Bocedi, A., and Marino, M. (2006). Structure-function relationship of estrogen receptor a and ß: impact on human health. Mol. Aspects Med., 27, 299-402.
8. Béliveau, R., and Gingras, D. (2007). Role of nutrition in preventing cancer. Can. Fam. Physician, 53, 1905-1911.
9. Benavente-García, O., and Castillo, J. (2008). Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J. Agric. Food Chem., 56, 6185-6205.
10. Bennetts, H.W., Underwood, E.J., and Shier, F.L. (1946). A specific breeding problem of sheep on subterranean clover pasture in western Australia. Austr. Vet. J., 22, 2-12.
11. Birt, D.F., Hendrich, S., and Wang, W. (2001). Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol. Ther., 90, 157-177.
12. Boots, A.W., Haenen, G.R., and Bast, A. (2008). Health effects of quercetin: from antioxidant to nutraceutical. Eur. J. Pharmacol., 585, 325-337.
13. Caltagirone, S., Rossi, C., Poggi, A., Ranelletti, F.O., Natali, P.G., Brunetti, M., Aiello, F.B., and Piantelli, M. (2000). Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. J. Cancer, 87, 595-600.
14. Chambliss, K.L., Yuhanna, I.S., Anderson, R.G., Mendelsohn, M. E., and Shaul, P.W. (2002). ERbeta has nongenomic action in caveolae. Mol. Endo., 16, 938-946.
15. Chao, S.H., Fujinaga, K., Marion, J.E., Taube, R., Sausville, E.A., Senderowicz, A.M., Peterlin B.M., and Price D.H. (2000). Flavopiridol inhibits P-TEFb and blocks HIV-1 replication. J. Biol. Chem., 275, 28345-28348.
16. Cheynier, V. (2005). Polyphenols in foods are more complex than often thought. Am. J. Clin. Nutr., 81, 223-229.
17. Chiang, A.N., Wu, H.L., Yeh, H.I., Chu, C.S., Lin, H.C., and Lee, W.C. (2006). Antioxidant effects of black rice extract through the induction of superoxide dismutase and catalase activities. Lipids, 41, 797-803.
18. Conney, A.H. (2003). Enzyme induction and dietary chemicals as approaches to cancer chemoprevention: the seventh DeWitt S. Goodman lecture. Cancer Res., 63, 7005-7031.
19. Dalu, A., Haskell, J.F., Coward, L., and Lamartiniere, C.A. (1998). Genistein, a component of soy, inhibits the expression of the EGF and ErbB2/Neu receptors in the rat dorsolateral prostate. Prostate, 37, 36-43.
20. Dang, Z.C., Audinot, V., Papapoulos, S.E., Boutin, J.A., and Lowik, C.W. (2003). PPARγ as a molecular target for the soy phytoestrogen genistein. J. Biol. Chem., 278, 962-967.
21. Dang, Z.C., and Lowik, C. (2005). Dose-dependent effects of phytoestrogens on bone. Trends Endocrinol. Metab., 16, 207-213.
22. Delclos, K.B., Bucci, T.J., Lomax, L.G., Latendresse, J.R., Warbritton, A., Weis, C.C., and Newbold, R.R. (2001). Effects of dietary genistein exposure during development on male and female CD (Sprague-Dawley) rats. Reprod. Toxicol., 15, 647-663.
23. Distefano, E., Marino, M., Gillette, J.A., Hanstein, B., Pallottini, V., Bruning, J., Krone, W., and Trentalance, A. (2002). Role of tyrosine kinase signaling in estrogen-induced LDL receptor gene expression in HepG2 cells. Biochim. Biophys. Acta, 1580, 145-149.
24. Doerge, D.R., Twaddle, N.C., Churchwell, M.I., Newbold, R.R., and Delclos, K.B. (2006). Lactational transfer of the soy isoflavone, genistein, in Sprague-Dawley rats consuming dietary genistein. Reprod. Toxicol., 21, 307-312.
25. El Bedoui, J., Oak, M.H., Anglard, P., and Schini-Kerth, V.B. (2005). Catechins prevent vascular smooth muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression. Cardiovasc. Res., 67, 317-325.
26. Elisaf, M. (2002). Effects of fibrates on serum metabolic parameters. Curr. Med. Res. Opin., 18, 269-276.
27. Escande, A., Pillon, A., Servant, N., Cravedi, J.P., Larrea, F., Muhn, P., Nicolas, J.C., Cavailles, V., and Balaguer, P. (2006). Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta. Biochem. Pharmacol., 71, 1459-1469.
28. Espìn, J.C., Garcìa-Conesa, M.T., and Tomàs-Barberàn, F.A. (2007). Nutraceuticals: facts and fiction. Phytochemistry, 68, 2986-3008.
29. Farach-Carson, M.C., and Davis, P.J. (2003). Steroid hormone interactions with target cells: cross talk between membrane and nuclear pathways. J. Pharmacol. Experimen. Ther., 307, 839-845.
30. Fenton, J.I., and Hord, N.G. (2004). Flavonoids promote cell migration in nontumorigenic colon epithelial cells differing in Apc genotype: implications of matrix metalloproteinase activity. Nutr. Cancer, 48, 182-188.
31. Filomeni, G., Graziani, I., Rotilio, G., and Ciriolo, M.R. (2007). Trans-resveratrol induces apoptosis in human breast cancer cells MCF-7 by the activation of MAP kinases pathways. Genes Nutr., 2, 295-305.
32. Fisher, J.S. (2004). Are all EDC effects mediated via steroid hormone receptors? Toxicol., 205, 33-41.
33. Flynn, K.M., Ferguson, S.A., Delclos, K.B. and Newbold, R.R. (2000). Effects of genistein exposure on sexually dimorphic behaviors in rats. Toxicol. Sci., 55, 311-319.
34. Galati, G., Moridani, M.Y., Chan, T.S., and O'Brien, P.J. (2001). Peroxidative metabolism of apigenin and naringenin versus luteolin and quercetin: glutathione oxidation and conjugation. Free Radic. Biol. Med., 30, 370-382.
35. Galati, G., Teng, S., Moridani, M.Y., Chan, T.S., and O'Brien, P.J. (2000). Cancer chemoprevention and apoptosis mechanisms induced by dietary polyphenolics. Drug Metabol. Drug Interact., 17, 311-349.
36. Galluzzo, P., Ascenzi, P., Bulzomi, P., and Marino, M. (2008). The nutritional flavanone naringenin triggers antiestrogenic effects by regulating estrogen receptor apalmitoylation. Endocrinology, 149, 2567-2575.
37. Galluzzo, P., Martini, C., Bulzomi, P., Leone, S., Bolli, A., Pallottini, V., and Marino, M. (2008a). Quercitin-induced apoptotic cascade in cancer cells: antioxidant versus estrogen receptor-dependent mechanisms. Mol. Nutr. Food Res., In Press.
38. Galluzzo, P., Caiazza, F., Moreno, S., and Marino, M. (2007). Role of ERbeta palmitoylation in the inhibition of human colon cancer cell proliferation. Endocr. Relat. Cancer, 359, 102-107.
39. Galluzzo, P., and Marino, M. (2006). Nutritional flavonoid impact on nuclear and extranuclear estrogen receptor activities. Genes Nutr. 1, 161-176.
40. Gronemeyer, H., Gustafsson, J.-Å., and Laudet, V. (2004). Principles for modulation of the nuclear receptor superfamily. Nat. Rev., Drug Discovery, 3, 950-964.
41. Guo, T.L., Germolec, D.R., Musgrove, D.L., Delclos, K.B., Newbold, R.R., Weis, C.C. and White, K.L.Jr. (2005). Myelotoxicity in genistein-, nonylphenol-, methoxychlor-, vinclozolin-or ethinyl estradiol-exposed F1 generations of Sprague-Dawley rats following developmental and adult exposures. Toxicology, 211, 207-219.
42. Hagiwara, M., Inoue, S., Tanaka, T., Nunoki, K., Ito, M., and Hidaka, H. (1988). Differential effects of flavonoids as inhibitors of tyrosine protein kinases and serine/threonine protein kinases. Biochem. Pharmacol., 37, 2987-2992.
43. Hanasaki, Y., Ogawa, S., and Fukui, S. (1994). The correlation between active oxygens scavenging and antioxidative effects of flavonoids. Free Rad. Biol. Med., 16, 845-850.
44. Hao, Q., Rutherford, S. A., Low, B., and Tang, H. (2006). Selective regulation of hydrogen peroxide signaling by receptor tyrosine phosphatase-a. Free Radic. Biol. Med., 41, 302-310.
45. Hehner, S.P., Hofmann, T.G., Dienz, O., Droge, W., and Schmitz, M. L. (2000). Tyrosine-phosphorylated Vav1 as a point of integration for T-cell receptor-and CD28-mediated activation of JNK, p38, and interleukin-2 transcription. J. Biol. Chem,. 275, 18160-18171.
46. Ioannides, C., and Lewis, D. F. (2004). Cytochromes P450 in the bioactivation of chemicals. Curr. Top. Med. Chem., 4, 1767-1788.
47. Iqbal, M. J., Yaegashi, S., Ahsan, R., Lightfoot, D.A., and Banz, W. J. (2002). Differentially abundant mRNAs in rat liver in response to diets containing soy protein isolate. Physiol. Genomics, 11, 219-226.
48. Jacobs, M.N., and Lewis, D.F. (2002). Steroid hormone receptors and dietary ligands: a selected review. Proc. Nutr. Soc., 61, 105-122.
49. Jakobs, S., Fridrich, D., Hofem, S., Pahlke, G., and Eisenbrand, G. (2006). Natural flavonoids are potent inhibitors of glycogen phosphorylase. Mol. Nutr. Food Res., 50, 52-57.
50. Kang Z.C., Tsai S.J., and Lee H. (1999). Quercetin inhibits benzo[a]pyrene-induced DNA adducts in human Hep G2 cells by altering cytochrome P-450 1A1 expression. Nutr. Cancer, 35, 175-179.
51. Karunagaran, D., Rashmi, R., and Kumar, T.R. (2005). Induction of apoptosis by curcumin and its implications for cancer therapy. Curr. Cancer Drug Targets, 5, 117-129.
52. Kim, E.J., Choi, C.H., Park, J.Y., Kang, S.K., and Kim, Y.K. (2008). Underlying mechanism of quercetin-induced cell death in human glioma cells. Neurochem. Res., 33, 971-979.
53. Kirk, E.A., Sutherland, P., Wang, S.A., Chait, A., and LeBoeuf, R.C. (1998). Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. J. Nutr., 128, 954-959.
54. Kuiper, G.G., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson. S., and Gustafsson, J.A. (1997). Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors a and ß. Endocrinology, 138, 863-870.
55. Kweon, M.H., In Park, Y., Sung, H.C., and Mukhtar, H. (2006). The novel antioxidant 3-Ocaffeoyl-1-methylquinic acid induces Nrf2-dependent phase II detoxifying genes and alters intracellular glutathione redox. Free Radic. Biol. Med., 40, 1349-1361.
56. Lee, J. S., and Surh, Y. J. (2005). Nrf2 as a novel molecular target for chemoprevention. Cancer Lett. 224, 171-184.
57. Levin, E.R. (2005). Integration of the extranuclear and nuclear actions of estrogen. Mol. Endocrinol., 19, 1951-1959.
58. Ling, S., Dai, A., Williams, M.R., Husband, A.J., Nestel, P.J., Komesaroff, P.A., and Sudhir, K. (2004). The isoflavone metabolite cis-tetrahydrodaidzein inhibits ERK-1 activation and proliferation in human vascular smooth muscle cells. J. Cardiovasc. Pharmacol., 435, 622-628.
59. Liu, M. M., Albanese, C., Anderson, C. M., Hilty, K., Webb, P., Uht, R. M., Price, R. H., Pestell, R. G., and Kushner, P. J. (2002). Opposing action of estrogen receptors a and b on cyclin D1 gene expression. J. Biol. Chem., 277, 24353-24360.
60. Manach, C., Scalbert, A., Morand, C., Remesy, C., and Jimenez L. (2004). Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr., 79, 727-747.
61. Manna, S.K., Mukhopadhyay, A. and Aggarwal, B.B. (2000). Resveratrol suppresses TNFainduced activation of nuclear transcription factors NF-κB, activator protein-1, and apoptosis: potential role of reactiveoxygen intermediates and lipid peroxidation. J. Immunol., 164, 6509-6519.
62. Manthey, J.A. (2000). Biological properties of flavonoids pertaining to inflammation, Microcirculation, 6, 29-34.
63. Marino, M., Acconcia, F., and Ascenzi P. (2005). Estrogen receptor signalling: bases for drug actions. Curr Drug Targets Imm. Endo. Metabol. Disorder., 5, 305-14.
64. Mezei, O., Banz, W.J., Steger, R.W., Peluso, M.R., Winters, T.A., and Shay, N. (2003). Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J. Nutr., 133, 1238-1243.
65. Middleton, E.Jr., Kandaswami, C., and Theoharides, T.C. (2000). The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev., 52, 673-751.
66. Miyoshi, N., Naniwa, K., Yamada, T., Osawa, T., and Nakamura, Y. (2007). Dietary flavonoid apigenin is a potential inducer of intracellular oxidative stress: The role in the interruptive apoptotic signal, Arch. Biochem. Biophys., 466, 274-82.
67. Mnif, W., Pascussi, J. M., Pillon, A., Escande, A., Bartegi, A., Nicolas, J. C., Cavaillès, V., Duchesne, M.J., and Balaguer, P. (2007). Estrogens and antiestrogens activate hPXR. Toxicol. Lett., 170, 19-29.
68. Moore, J.T., and Kliewer, S.A. (2000). Use of the nuclear receptor PXR to predict drug interactions. Toxicol., 153, 1-10.
69. Morrissey C., O'Neill A., Spengler B., Christoffel V., Fitzpatrick J.M., and Watson R.W. (2005). Apigenin drives the production of reactive oxygen species and initiates a mitochondrial mediated cell death pathway in prostate epithelial cells. Prostate, 63, 131-142.
70. Moskaug, J.O., Carlsen, H., Myhrstad, M.C., and Blomhoff, R. (2005). Polyphenols and glutathione synthesis regulation. Am. J. Clin. Nutr., 81, 277-283.
71. Mueller, S. O. (2002). Overview of in vitro tools to assess the estrogenic and antiestrogenic activity of phytoestrogens. J. Chromatogr., 777, 155-165.
72. Mueller, S.O., Simon, S., Chae, K., Metzler, M., and Korach, K.S. (2004). Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol. Sci., 80, 14-25.
73. Nilsson, S., Makela, S., Treuter, E., Tujague, M., Thomsen, J., Andersson, G., Enmark, E., Pettersson, K., Warner, M., and Gustafsson, J.-Å. (2001). Mechanism of estrogen action, Physiol. Rev., 81, 1535-1565.
74. Nomura, M., Takahashi, T., Nagata, N., Tsutsumi, K., Kobayashi, S., Akiba, T., Yokogawa, K., Moritani, S., and Miyamoto, K. (2008). Inhibitory mechanisms of flavonoids on insulin-stimulated glucose uptake in MC3T3-G2/PA6 adipose cells. Biol. Pharm. Bull., 31, 1403-9.
75. O'Brien P.J. (2000). Peroxidases, Chem. Biol. Interact., 129, 113-139.
76. O'Loghlen, A., Perez-Morgado, M.I., Salinas, M., and Martin, M.E. (2003). Reversible inhibition of the protein phosphatase 1 by hydrogen peroxide: potential regulation of eIF2a phosphorylation in differentiated PC12 cells. Arch. Biochem. Biophys., 417, 194-202.
77. Pellegatta, F., Bertelli, A.A.E., Staels, B., Duhem, C., Fulgenzi, A., and Ferrero, M.E. (2003). Different short-and long-term effects of resveratrol on nuclear factor-kappaB phosphorylation and nuclear appearance in human endothelial cells. Am. J. Clin. Nutr., 77, 1220-1228.
78. Peterson, G., Barnes, S. (1993). Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate, 22, 335-345.
79. Peterson, G., Barnes, S. (1996). Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells. Cell Growth Differ., 7, 1345-1351.
80. Rice, S., and Whitehead, S.A. (2006). Phytoestrogens and breast cancer-promoters or protectors?, Endocr. Relat. Cancer, 13, 995-1015.
81. Ricketts, M.L., Moore, D.D., Banz, W.J., Mezei, O., and Shay, N.F. (2005). Molecular mechanisms of action of the soy isoflavones includes activation of promiscuous nuclear receptors. J. Nutr. Biochem., 16, 321-330.
82. Saarinen, N.M., Mäkelä, S., Penttinen, P., Wärri, A., Lorenzetti, S., Virgili, F., Mortensen, A., Sørensen, I.K., Bingham, C., Valsta, L.M., Vollmer, G., and Zierau, O. (2006). Tools to evaluate estrogenic potency of dietary phytoestrogens: a consensus paper from the EU Thematic Network "Phytohealth"; (QLKI-2002-2453). Genes Nutr., 1, 143-158.
83. Shay, N. F., and Banz, W. J. (2005). Regulation of gene transcription by botanicals: novel regulatory mechanisms. Ann. Rev. Nutr., 25, 297-315.
84. Somjen, D., Kohen, E., Lieberherr, M., Gayer, B., Schejter, E., Katzburg, S., Limor, R., Sharon, O., Knoll, E., Posner, G.H., Kaye, A.M., and Stern, N. (2005). Membranal effects of phytoestrogens and carboxy derivatives of phytoestrogens on human vascular and bone cells: new insights based on studies with carboxy-biochanin. A. J. Steroid Biochem. Mol. Biol., 93, 293-303.
85. Spencer, J.P., Rice-Evans, C., Williams, R.J. (2003). Modulation of pro-survival Akt/protein kinase B and ERK1/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J. Biol. Chem., 278, 34783-34793.
86. Stevens, J.F., and Page, J. E. (2004). Xanthohumol and related prenylflavonoids from hops and beer: to your good health!, Phytochem., 65, 1317-1330.
87. Stevenson, D.E., and Hurst, R.D. (2007). Polyphenolic phytochemicals-just antioxidants or much more?, Cell Mol. Life Sci., 64, 2900-2916.
88. Stone, J.R., and Yang, S. (2006). Hydrogen peroxide: a signaling messenger. Antioxid. Redox Signaling, 8, 243-270.
89. Suetsugi, M., Su, L., Karlsberg, K., Yuan, Y.C., and Chen, S. (2003). Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors. Mol. Cancer Res., 1, 981-991.
90. Surh, Y.J. (2003). Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer, 3, 768-780.
91. Terasaka, S., Aita, Y., Inoue, A., Hayashi, S., Nishigaki, M., Aoyagi, K., Sasaki, H., Wada-Kiyama, Y., Sakuma, Y., Akaba, S., Tanaka, J., Sone, H., Yonemoto, J., Tanji, M., and Kiyama, R.U. (2004). Using a customized DNA microarray for expression profiling of the estrogen-responsive genes to evaluate estrogen activity among naturalestrogens and industrial chemicals. Environ. Health Perspect., 112, 773-781.
92. Tomar, R.S,. and Shiao, R. (2008). Early Life and Adult Exposure to Isoflavones and Breast Cancer Risk. J. Environ. Sci. Health C. Environ. Carcinog. Ecotoxicol. Rev., 26, 113-73.
93. Totta, P., Acconcia, F., Leone, S., Cardillo, I., and Marino, M. (2004). Mechanisms of naringenin-induced apoptotic cascade in cancer cells: involvement of estrogen receptor a and ß signalling. IUBMB Life, 56, 491-499.
94. Totta, P., Acconcia, F., Virgili, F., Cassidy, A., Weinberg, P.D., Rimbach, G., and Marino, M. (2005). Daidzein-sulfate metabolites affect transcriptional and antiproliferative activities of estrogen receptor-beta in cultured human cancer cells. J. Nutr., 135, 2687-2693.
95. Ueda, S., Nakamura, H., Masutani, H., Sasada, T., Takabayashi, A., Yamaoka, Y., and Yodoi, J. (2002). Baicalin induces apoptosis via mitochondrial pathway as prooxidant, Mol. Immunol., 38, 781-91.
96. Ursini, F., Maiorino, M., Morazzoni, P., Roveri, A., and Pifferi, G. (1994). A novel antioxidant flavonoid (IdB 1031) affecting molecular mechanisms of cellular activation. Free Rad. Biol. Med., 16, 547-553.
97. Vargo M.A., Voss O.H., Poustka F., Cardounel A.J., Grotewold E., and Doseff A.I. (2006). Apigenin-induced-apoptosis is mediated by the activation of PKCd and caspases in leukemia cells. Biochem. Pharmacol., 72, 681-692.
98. Virgili, F., and Marino, M. (2008). Regulation of cellular signals from nutritional molecules: a specific role for phytochemicals, beyond antioxidant activity. Free Radic. Biol. Med., 45, 1205-1216.
99. Virgili, F., Acconcia, F., Ambra, R., Rinna, A., Totta, P., and Marino, M. (2004). Nutritional flavonoids modulate estrogen receptor a signaling. IUBMB Life, 56, 145-151.
100. Wang I.K., Lin-Shiau S.Y., and Lin J.K. (1999). Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase3 in leukaemia HL-60 cells. Eur. J. Cancer, 35, 1517-1525.
101. Wang, H., Huang, H., Li, H., Teotico, D.G., Sinz, M., Baker, S.D., Staudinger, J., Kalpana, G., Redinbo, M.R., and Mani, S. (2007). Activated pregnenolone X-receptor is a target for ketoconazole and its analogs. Clin. Cancer Res., 13, 2488-2495.
102. Watson, C.S., Bulayeva, N.N., Wozniak, A.L., and Finnerty, C.C. (2005). Signaling from the membrane via membrane estrogen receptor-alpha: estrogens, xenoestrogens and phytoestrogens. Steroids, 70, 364-371.
103. Wung B.S., Hsu M.C., Wu C.C., and Hsieh C.W. (2005). Resveratrol suppresses IL-6induced ICAM-1 gene expression in endothelial cells: Effects on the inhibition of STAT3 phosphorylation. Life Sciences, 78, 389-397.
104. Zhang, X., Shu, X.O., Gao, Y., Yang, G., Li, Q., Li, H., Jin, F., and Zheng, W. (2003). Soy food consumption is associated with lower risk of coronory heart disease in Chinese women. J. Nutr., 133, 2874-2878.